Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.58 HKD | -0.82% |
|
-5.81% | -51.24% |
03/06 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
30/05 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- 1541 Stock
- News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Official Publications